2025年，国家医保局牵头办理的建议提案问题已解决或采纳206件

Core Viewpoint - The National Healthcare Security Administration (NHSA) is actively promoting the implementation of suggestions from national representatives and committee members to accelerate the development of innovative drugs, significantly improving patient access and affordability [2][3]. Group 1: Policy Initiatives - NHSA has released 16 measures to support the development of innovative drugs, covering areas such as research support, medical insurance access, clinical application, and diversified payment systems [3]. - By the end of 2025, nearly 500 billion yuan has been spent from the medical insurance fund on negotiated drugs, providing stability and confidence for innovative drug companies [3]. - In 2025, NHSA has resolved or adopted 206 issues related to suggestions and proposals, implementing 29 related policy measures and incorporating 40 suggestions from representatives and committee members [3][4]. Group 2: Stakeholder Engagement - NHSA has engaged with representatives and committee members through various methods, including special seminars, field research, and telephone communication, to understand their demands and involve them in policy formulation [2][4]. - The agency has organized a series of seminars to listen to the needs of frontline pharmaceutical companies, research institutions, and medical organizations [3]. Group 3: Future Directions - NHSA plans to continuously innovate its working methods and strengthen communication with representatives and committee members to address key issues of concern, aiming to enhance the effectiveness of suggestion and proposal handling [4].